Tesla Delivers Mixed Q1 Revenue Miss Profit Beat as Auto Margins Strengthen London Stock Exchange Group Reports Income Growth Driven by Tradeweb Platform Oils Sudden Reversal Highlights Persistent Geopolitical Premium in Crude Markets Lake Street Maintains Positive Outlook on Velo3D Following Q1 Earnings Release Coal India Plans Syngas Projects to Offset Tightening Gas Supply for Power and Fertilizer Sectors Charter Communications Improved Buyout Offer for Liberty Broadband Signals Strategic Consolidation Globant Q1 2026 Earnings Mixed Quarter with Slight EPS Miss and Modest Stock Decline Central Garden Pet CENT Q1 2026 Earnings Strong EPS Beat of 154 Drives Modest Stock Gains Digi International Inc DGII Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Lesaka Technologies Q1 2026 Earnings EPS Surges Past Estimates with 978 Surprise KOF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment LBRDP Q3 2025 Earnings Strong EPS Surprise Highlights Resilient Performance United Parks Resorts PRKS Jumps Nearly 6 A Look at the Momentum and Key Levels Encore Capital Group ECPG Advances 168 Approaching Key Resistance at 8563 Impact BioMedical Inc IBO Edges Higher as Stock Tests Support Near 051 STRD Preferred Stock Holds Steady Near Support as Trading Remains Muted Alpha Modus Holdings AMOD Tests Key Support as Price Slips 196 to 020 US Stock Futures and Bond Yields Slide After Putins Nuclear Doctrine Update AGNC Q1 2026 Earnings EPS Beats Estimates by 145 Amid Stock Decline WaFd Inc WAFD Edges Higher Support Holds as Stock Navigates Tight Range SunCoke Energy SXC Q1 2026 Earnings EPS Misses Estimates by 6956 Despite Sharp Stock Rally Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs AIRG Q1 2026 Earnings EPS Miss Slightly but Shares Rise on Operational Highlights APYX Q1 2026 Earnings EPS Surprise of 5375 Drives Narrowed Loss Stock Declines CING Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Stock Movement ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline LMND Q1 2026 Earnings EPS Beat Estimates by 186 but Stock Slips